Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented The Engine Ventures in the transaction. The Engine Ventures, a venture firm, announced the formation of Fund III,...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Incode Technologies Inc. in the transaction. Incode Technologies Inc. (Incode), a global leader in trust and identity, announced...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Companyon Ventures in the deal. Companyon Ventures announced the formation of its third investment fund. Companyon Ventures Fund...
You must be a Standard 1 Year member to access this content.
Cooley served as U.S. counsel to Harness with DLA Piper Argentina advising under Argentine law, while Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Split Software....
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised Gameto on the deal, and Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Two Sigma Ventures. Gameto, a biotechnology...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Radar Therapeutics on the deal, and Wilson Sonsini Goodrich & Rosati advised Radar Therapeutics on IP matters related...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented ThinkLabs AI on the transaction. ThinkLabs AI, a startup focused on developing technology to help enhance grid planning,...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented NG.CASH in the transaction. NG.CASH, a fintech focused on Generation Z, announced it raised R$65 million (appr. USD$12.69...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Foresite Capital in the transaction. Cullinan Therapeutics, Inc. (formerly Cullinan Oncology, Inc.) (Nasdaq: CGEM; “Cullinan”), a biopharmaceutical company,...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Aplazo in the transaction. Aplazo announced it has raised $45 million in Series B financing led by QED....
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Brixton Biosciences in the transaction. Brixton Biosciences, a clinical stage life sciences company, announced it has raised $33...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Level One Fund in the transaction. Allergen-free F&B manufacturer Voyage Foods announced it has secured $52 million in...
You must be a Standard 1 Year member to access this content.
